Transplantation Proceedings
Volume 41, Issue 1 , Pages 36-39 , January 2009

The New Strategy of Liver Transplantation From Marginal Donors Using Serine Protease Inhibitor

References 

  1. Melemdz HV, Heaton ND. Understanding “marginal” liver grafts. Transplantation. 1999;68:469
  2. Miyagi S, Ohkohchi N, Oikawa K, et al. Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft. Transplantation. 2004;77:1487
  3. Satoh M, Ohkohchi N, Tsukamoto S, et al. Successful live transplantation from agonal non-heart-beating donors in pigs. Transplant Int. 2003;16:100
  4. Tsukamoto S, Ohkohchi N, Fukumori T, et al. Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart beating donors. Transplantation. 1999;67:1396
  5. Kawazoe Y, Eguchi S, Sugiyama N, et al. Protective effect of nafamostat mesilate on injury of porcine hepatocytes by human plasma. Cell Transplant. 1999;8:419

 This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, and from the Ministry of Welfare of Japan, and by a grant from Tohoku University Graduate School of Medicine.

PII: S0041-1345(08)01610-2

doi: 10.1016/j.transproceed.2008.09.066

Transplantation Proceedings
Volume 41, Issue 1 , Pages 36-39 , January 2009

Article Tools

* Image Usage & Resolution